Jeffrey S Borer Selected Research

Systolic Heart Failure

12/2019	Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
1/2017	Financial impact of ivabradine on reducing heart failure penalties under the Hospital Readmission Reduction Program.
1/2017	Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris.
12/2016	Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.
9/2016	Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States.
1/2016	Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT.
1/2016	Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of SHIFT.
12/2015	Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial).
12/2015	Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial.
10/2015	Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunction.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey S Borer Research Topics

Disease

43	Heart Failure 12/2019 - 01/2002
21	Systolic Heart Failure 12/2019 - 01/2010
9	Coronary Artery Disease (Coronary Atherosclerosis) 11/2017 - 05/2006
8	Left Ventricular Dysfunction 12/2016 - 09/2006
6	Arthritis (Polyarthritis) 11/2017 - 08/2003
6	Myocardial Infarction 01/2017 - 01/2006
6	Bradycardia 12/2016 - 09/2008
6	Stable Angina 07/2012 - 02/2003
5	Cardiovascular Diseases (Cardiovascular Disease) 03/2018 - 01/2011
5	Osteoarthritis 01/2018 - 04/2009
5	Rheumatoid Arthritis 01/2018 - 04/2009
5	Hypertension (High Blood Pressure) 11/2017 - 10/2005
4	Stroke (Strokes) 12/2016 - 01/2007
4	Coronary Disease (Coronary Heart Disease) 12/2016 - 09/2006
4	Diabetes Mellitus 01/2016 - 01/2010
3	Atrial Fibrillation 12/2016 - 06/2014
3	Aortic Valve Insufficiency (Aortic Regurgitation) 01/2009 - 10/2005
3	Fibrosis (Cirrhosis) 01/2009 - 09/2004
2	Gout 01/2022 - 03/2018
2	Cardiomyopathies (Cardiomyopathy) 12/2019 - 10/2011
2	Angina Pectoris 01/2017 - 01/2010
2	Inflammation (Inflammations) 01/2014 - 01/2005
2	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2014 - 06/2013
1	Ventricular Remodeling 01/2016
1	Peripheral Arterial Disease 12/2015
1	Anemia 12/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2015
1	Heart Valve Diseases (Valvular Heart Disease) 09/2015
1	Bundle-Branch Block (Fascicular Block) 04/2015
1	Hemorrhage 01/2014
1	Acute Coronary Syndrome 01/2014
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 05/2013
1	Type 2 Diabetes Mellitus (MODY) 09/2010
1	Neointima 05/2009
1	Tachycardia (Tachyarrhythmias) 09/2008
1	Hypotension (Low Blood Pressure) 01/2008
1	Heart Diseases (Heart Disease) 01/2007
1	Confusion (Bewilderment) 01/2006
1	Isolated Systolic Hypertension 10/2005

Drug/Important Bio-Agent (IBA)

39	IvabradineIBA 12/2019 - 02/2003
7	Celecoxib (Celebrex)FDA Link 01/2018 - 08/2003
7	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2017 - 08/2003
5	Naproxen (Naprosyn)FDA LinkGeneric 01/2018 - 04/2009
5	Ibuprofen (Motrin)FDA LinkGeneric 01/2018 - 04/2009
3	Pharmaceutical PreparationsIBA 01/2018 - 08/2003
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2015 - 09/2006
3	CollagenIBA 05/2009 - 01/2006
3	Fibronectins (Fibronectin)IBA 01/2009 - 01/2006
2	Allopurinol (Remid)FDA LinkGeneric 01/2022 - 03/2018
2	Febuxostat FDA Link 01/2022 - 03/2018
2	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2015 - 07/2012
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2007 - 08/2003
1	Uric Acid (Urate)IBA 01/2022
1	Xanthine OxidaseIBA 03/2018
1	purineIBA 03/2018
1	PlacebosIBA 11/2017
1	Cardiovascular AgentsIBA 04/2015
1	CholesterolIBA 04/2015
1	CreatinineIBA 04/2015
1	Indicators and Reagents (Reagents)IBA 03/2015
1	Carvedilol (Coreg)FDA LinkGeneric 01/2015
1	Bisoprolol (Concor)FDA LinkGeneric 01/2015
1	Nebivolol FDA Link 01/2015
1	Diphosphonates (Bisphosphonates)IBA 06/2014
1	Warfarin (Coumadin)FDA LinkGeneric 01/2014
1	Vasodilator Agents (Vasodilators)IBA 01/2014
1	Factor Xa (Coagulation Factor Xa)IBA 01/2014
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2014
1	Factor Xa InhibitorsIBA 01/2014
1	Reducing AgentsIBA 11/2013
1	omega-Chloroacetophenone (Mace)IBA 05/2013
1	Atenolol (Tenormin)FDA LinkGeneric 07/2012
1	Verapamil (Calan)FDA LinkGeneric 07/2012
1	Diltiazem (Cardizem)FDA LinkGeneric 07/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2010
1	Glucose (Dextrose)FDA LinkGeneric 01/2010
1	ElastinIBA 05/2009
1	Spironolactone (Aldactone)FDA LinkGeneric 05/2009
1	Matrix Metalloproteinases (MMPs)IBA 01/2009
1	NitratesIBA 01/2009
1	Mitogen-Activated Protein KinasesIBA 01/2009
1	fibronectinaseIBA 01/2009
1	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 01/2007
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2006
1	trandolapril (Mavik)FDA LinkGeneric 09/2006
1	Perindopril FDA LinkGeneric 09/2006
1	Ramipril (Altace)FDA LinkGeneric 09/2006
1	Glycoproteins (Glycoprotein)IBA 01/2006
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2006

Therapy/Procedure

19	Therapeutics 12/2019 - 01/2002
7	Cardiac Resynchronization Therapy 01/2018 - 10/2013
2	Aftercare (After-Treatment) 01/2022 - 12/2016
2	Drug Therapy (Chemotherapy) 01/2018 - 09/2015
2	Patient Readmission 01/2017 - 03/2015
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2012 - 01/2006
1	Preoperative Exercise 06/2013
1	Percutaneous Coronary Intervention 04/2012
1	Pain Management 04/2009
1	Withholding Treatment 09/2008
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2008